Insider trading · Q3 2026 · CIK 49071

Humana Inc (HUM) insider trading.

In Q3 2026, insiders at Humana Inc reported 3 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales.

Transactions
3
Purchases (P)
0
Sales (S)
0
Net shares, P minus S
0
Insiders
3
Last filed
2026-09-03

Insiders

InsiderRelationshipTransactionsBuysSales
Nundy ShantanuOfficer · Chief Medical Officer100
Crawford Frederick JohnDirector100
Smith Paul JohnDirector100

Transactions

3 non-derivative rows, newest transaction first. Shares and prices as filed.
DateInsiderCodeSharesPriceOwned afterFiling
2026-09-01Nundy ShantanuA (A)2,549$02,549Form 4
2026-08-01Crawford Frederick JohnA (A)544$0544Form 4
2026-08-01Smith Paul JohnA (A)544$0544Form 4

Transaction codes in this quarter

Get HUM insider transactions through the API

Request with your API key
curl "https://sec-api.dev/api/v1/insider-transactions?period=2026q3&cik=49071&limit=100" \
  -H "Authorization: Bearer $SEC_API_KEY"

Insider trading API guide · HUM company page · Humana Inc on SEC.gov

Questions

Are insiders buying or selling Humana Inc (HUM)?

In Q3 2026, insiders at Humana Inc reported 3 non-derivative transactions on 7 Forms 3, 4 and 5: 0 open-market purchases and 0 sales. Grants, tax withholding and option exercises are counted as transactions but are not purchases or sales.

Where do these Humana Inc insider trades come from?

From the SEC Insider Transactions Data Sets for Q3 2026, which republish the Forms 3, 4 and 5 filed on EDGAR. Each row links to its filing on SEC.gov.

Source: SEC Insider Transactions Data Sets, Q3 2026, retrieved 2026-10-27. Footnotes, derivative holdings and amendments are in the linked filings. Not investment advice.

Plain-text version for agents and LLMs: /insider-trading/hum.md

Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.